Mizukawa B, Wei J, Shrestha M, Wunderlich M, Chou FS, Griesinger A, Harris CE, Kumar AR, Zheng Y, Williams DA, Mulloy JC. Inhibition of Rac GTPase signaling and downstream prosurvival Bcl-2 proteins as combination targeted therapy in MLL-AF9 leukemia. Blood. 2011 Nov 10;118(19):5235-45.
Chou FS, Wunderlich M, Griesinger A, Mulloy JC. N-RasG12D induces features of stepwise transformation in preleukemic human umbilical cord blood cultures expressing the AML1-ETO fusion gene.Blood. 2011 Feb 17;117(7):2237-40.
Mulloy JC. Peripheral T cell lymphoma: new model + new insight.J Exp Med. 2010 May 10;207(5):911-3.
Mulloy JC, Cancelas JA, Filippi MD, Kalfa TA, Guo F, Zheng Y. Rho GTPases in hematopoiesis and hemopathies.Blood. 2010 Feb 4;115(5):936-47.
Link KA, Chou FS, Mulloy JC. Core binding factor at the crossroads: determining the fate of the HSC.J Cell Physiol. 2010 Jan;222(1):50-6. Review.
Wunderlich M, Mulloy JC. Model systems for examining effects of leukemia-associated oncogenes in primary human CD34+ cells via retroviral transduction. Methods Mol Biol. 2009;538:263-85.
Bosco EE, Mulloy JC, Zheng Y. Rac1 GTPase: a "Rac" of all trades.Cell Mol Life Sci. 2009 Feb;66(3):370-4. Review.
Mulloy JC, Wunderlich M, Zheng Y, Wei J. Transforming human blood stem and progenitor cells: a new way forward in leukemia modeling.Cell Cycle. 2008 Nov 1;7(21):3314-9.
Wei J, Wunderlich M, Fox C, Alvarez S, Cigudosa JC, Wilhelm JS, Zheng Y, Cancelas JA, Gu Y, Jansen M, Dimartino JF, Mulloy JC. Microenvironment determines lineage fate in a human model of MLL-AF9 leukemia.Cancer Cell. 2008 Jun;13(6):483-95.
Krejci O, Wunderlich M, Geiger H, Chou FS, Schleimer D, Jansen M, Andreassen PR, Mulloy JC. p53 signaling in response to increased DNA damage sensitizes AML1-ETO cells to stress-induced death.Blood. 2008 Feb 15;111(4):2190-9.
